Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
In a 2022 response to a Freedom of Information request, the UK governments Medicines and Healthcare products Regulatory Agency (MHRA) confirmed that products containing Melanotan II are unlicensed
If these injections are not used in the correct amount then it can cause serious issues
The businesses getting hit arent rogue operations
Further research and appropriate regulatory evaluation are required before conclusions about clinical use can be drawn
Diabetes constituted the majority of indications (n = 16,863, 58.2%), followed by weight control (n = 1,352, 4.7%) and non-diabetic blood glucose abnormalities (n = 556, 1.9%)
US$ 20.98
US$ 28.36
US$ 20.30
US$ 21.74
